Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 6.3197.66-47.11-18.43-26.72

What is the latest EBIT Growth ratio of BLISS GVS PHARMA ?

The latest EBIT Growth ratio of BLISS GVS PHARMA is 6.31 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar20246.31
Mar202397.66
Mar2022-47.11
Mar2021-18.43
Mar2020-26.72

How is EBIT Growth of BLISS GVS PHARMA Trending?

Years EBIT Growth % Change
Mar2024 6.31
-93.54
Mar2023 97.66
Positive
Mar2022 -47.11
Negative
Mar2021 -18.43
Negative
Mar2020 -26.72 -

Other Financial Ratios of BLISS GVS PHARMA


Compare EBIT Growth ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,316.4 Cr 7.3% 9% 10.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,136.0 Cr 6% 4% 9.9% Stock Analytics
DIVIS LABORATORIES ₹149,680.0 Cr 4.7% 0.3% 52.4% Stock Analytics
CIPLA ₹122,394.0 Cr 7% 3.7% 7.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,159.0 Cr 4.1% 6.4% 25% Stock Analytics
DR REDDYS LABORATORIES ₹97,105.6 Cr 6.3% 5% -4.7% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

7.3%

9%

10.2%

SENSEX

5.8%

6.1%

4.7%


You may also like the below Video Courses